deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03116828

A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures

Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects With Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial

Sponsor: Sumitomo Pharma America, Inc.

Conditions Epilepsy With Partial On-set Seizures
Interventions Eslicarbazepine Acetate Eslicarbazepine acetate
Updated 27 times since 2017 Last updated: Jun 14, 2020 Started: Jul 7, 2017 Primary completion: Jun 6, 2019 Completion: Jun 6, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03116828, this PHASE4 trial focuses on Epilepsy With Partial On-set Seizures and remains completed. Sponsored by Sumitomo Pharma America, Inc., it has been updated 27 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~May 2017 – ~Jul 2017 · 2 months · monthly snapshot~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshot~Aug 2017 – ~Sep 2017 · 31 days · monthly snapshot~Sep 2017 – ~Oct 2017 · 30 days · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Feb 2018 · 31 days · monthly snapshot~Feb 2018 – ~Mar 2018 · 28 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Apr 2019 · 4 months · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Jul 2020 · 12 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2023 · 32 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

27 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Sep 2023 [monthly]

    Completed PHASE4

▶ Show 22 earlier versions

  1. Jul 2020 — Jan 2021 [monthly]

    Completed PHASE4

  2. Jul 2019 — Jul 2020 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  3. Apr 2019 — Jul 2019 [monthly]

    Active Not Recruiting PHASE4

  4. Dec 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  5. Nov 2018 — Dec 2018 [monthly]

    Recruiting PHASE4

  6. Oct 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

  7. Sep 2018 — Oct 2018 [monthly]

    Recruiting PHASE4

  8. Aug 2018 — Sep 2018 [monthly]

    Recruiting PHASE4

  9. Jul 2018 — Aug 2018 [monthly]

    Recruiting PHASE4

  10. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE4

  11. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  12. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE4

  13. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE4

  14. Feb 2018 — Mar 2018 [monthly]

    Recruiting PHASE4

  15. Jan 2018 — Feb 2018 [monthly]

    Recruiting PHASE4

  16. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE4

  17. Nov 2017 — Dec 2017 [monthly]

    Recruiting PHASE4

  18. Oct 2017 — Nov 2017 [monthly]

    Recruiting PHASE4

  19. Sep 2017 — Oct 2017 [monthly]

    Recruiting PHASE4

  20. Aug 2017 — Sep 2017 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  21. Jul 2017 — Aug 2017 [monthly]

    Not Yet Recruiting PHASE4

  22. May 2017 — Jul 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sumitomo Pharma America, Inc.
Data source: Sumitomo Pharma America, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Austin, United States , Bethesda, United States , Boca Raton, United States , Boise, United States , Chapel Hill, United States , Charlotte, United States , Chicago, United States , Cincinnati, United States , Dallas, United States , Detroit, United States and 41 more locations